Renaissance Technologies - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 26 filers reported holding CASI PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$126,000
-89.2%
155,300
-89.3%
0.00%
-100.0%
Q4 2021$1,166,000
-39.5%
1,458,070
-9.9%
0.00%
-50.0%
Q3 2021$1,926,000
-19.6%
1,618,155
+4.6%
0.00%
-33.3%
Q2 2021$2,397,000
+290.4%
1,546,306
+504.7%
0.00%
+200.0%
Q1 2021$614,000
+193.8%
255,700
+261.1%
0.00%
Q4 2020$209,000
-77.2%
70,813
-88.2%
0.00%
-100.0%
Q3 2020$915,000
+1265.7%
597,730
+2130.3%
0.00%
Q2 2020$67,000
-44.2%
26,800
-36.1%
0.00%
Q1 2019$120,000
-31.0%
41,940
+0.3%
0.00%
Q2 2018$174,0000.0%41,8000.0%0.00%
Q1 2018$174,000
-64.4%
41,800
-72.2%
0.00%
-100.0%
Q4 2017$489,000
+144.5%
150,600
+33.4%
0.00%
Q3 2017$200,000
+78.6%
112,900
+6.3%
0.00%
Q2 2017$112,000
-30.0%
106,200
-5.8%
0.00%
Q1 2017$160,000
+11.1%
112,726
-9.7%
0.00%
Q4 2016$144,000
+111.8%
124,800
+103.6%
0.00%
Q3 2016$68,000
+9.7%
61,300
+16.5%
0.00%
Q2 2016$62,000
+34.8%
52,600
+20.4%
0.00%
Q1 2016$46,000
+24.3%
43,700
+14.1%
0.00%
Q4 2015$37,000
+2.8%
38,300
+15.0%
0.00%
Q3 2015$36,000
-25.0%
33,300
+23.8%
0.00%
Q2 2015$48,000
+65.5%
26,900
+35.2%
0.00%
Q1 2015$29,000
+52.6%
19,900
+39.2%
0.00%
Q4 2014$19,00014,3000.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
IDG-Accel China Growth Fund III Associates L.P. 7,973,536$23,522,00027.18%
Consonance Capital Management LP 7,576,431$22,350,0002.09%
Wellington Shields & Co., LLC 1,812,769$5,348,0001.92%
Wellington Shields Capital Management, LLC 2,071,765$6,112,0000.82%
Ikarian Capital, LLC 1,268,154$3,741,0000.16%
Sio Capital Management, LLC 203,432$600,0000.12%
Zebra Capital Management LLC 11,182$33,0000.04%
FEDERATED HERMES, INC. 7,000,000$20,650,0000.04%
GSA CAPITAL PARTNERS LLP 52,146$154,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 161,949$478,0000.02%
View complete list of CASI PHARMACEUTICALS INC shareholders